title: Sleep medicine pharmacotherapeutics overview: today, tomorrow, and the future (part 2: hypersomnia, parasomnia, and movement disorders).
abstract: Over the past 10 years, significant strides have been made in therapeutics for sleep disorders. In this second installment of a two-part review series, we discuss the current evidence surrounding the mechanisms of actions, indications, efficacy, and adverse side effects associated with the current over-the-counter and pharmacotherapeutics for hypersomnia, parasomnias, and movement disorders of sleep.
authors.affiliation: Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD. Electronic address: sgulyan1@jhmi.edu.
authors.forename: Seema
authors.initials: S
authors.lastname: Gulyani
authors.affiliation: Department of Neurology, Johns Hopkins University, Baltimore, MD.
authors.forename: Rachel E
authors.initials: RE
authors.lastname: Salas
authors.affiliation: Department of Neurology, Johns Hopkins University, Baltimore, MD.
authors.forename: Charlene E
authors.initials: CE
authors.lastname: Gamaldo
mesh_terms: D006970:Disorders of Excessive Somnolence / Q000188:drug therapy*; D004358:Drug Therapy / Q000639:trends; D006801:Humans; D020447:Parasomnias / Q000188:drug therapy*